T-cell Leukemia Lymphoma
📧 Sign up to get email alerts when something new happens for T-cell Leukemia Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
NCI-sponsored clinical trial update describes collecting human samples to study hairy cell leukemia and other leukemias, and to develop reco…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Tissue Collection for Studies of Lymph Cancer
Clinical trial update describing tissue collection for studies of lymph cancers; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma [Phase 2]
An ongoing Phase 2 study evaluating maintenance therapy with ruxolitinib after hematopoietic stem cell transplant in patients with T-cell ly…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
This clinical trial update describes biospecimen procurement for the Center for Immuno-Oncology immunotherapy protocols. It covers recruitin…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma [Phase 1]
Phase 1 trial evaluating azacitidine with abatacept for relapsed or refractory T-cell lymphomas is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1 [Phase 2]
Phase 2 trial of mogamulizumab to prevent adult T-cell leukemia/lymphoma in HTLV-1–infected individuals; currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma [Phase 1]
A Phase 1 trial evaluating third-party allogeneic natural killer cells together with mogamulizumab for relapsed or refractory adult T-cell l…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: A Phase I/II Study of OJP-001 in Patients With Adult T-cell Leukemia/Lymphoma [Phase 1, Phase 2]
A Phase I/II clinical trial evaluating OJP-001 in adults with Adult T-cell leukemia/lymphoma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Venetoclax Combined With Azacitidine, Chidamide, Vindesine, and Dexamethasone in Newly Diagnosed ETP-ALL Like Patients [Phase 2]
Phase 2 clinical trial evaluating a venetoclax-based combination with azacitidine, chidamide, vindesine, and dexamethasone in newly diagnose…
-
CLINICAL_TRIALS research · 2025-05-21Clinical Trial Update: A Registry for People With T-cell Lymphoma
A registry study at Memorial Sloan Kettering Cancer Center to enroll people with various T-cell and NK-cell lymphomas; the trial is currentl…
-
CLINICAL_TRIALS research · 2025-04-29Clinical Trial Update: Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic Malignancies [Phase 1]
This clinical trial update describes a Phase 1 dose-escalation and dose-expansion study of anti-CD7 allogeneic CAR T-cells (WU-CART-007) in …